Norbert G. Riedel
Director · Jazz Pharmaceuticals plc
IndividualSelling only
- 2025
- Sep 2, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Norbert G. Riedel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $27.78M in JAZZ purchases and sales in the last 12 months
- Robert Iannone - $20.41M in JAZZ purchases and sales in the last 12 months
- Neena M. Patil - $11.50M in JAZZ purchases and sales in the last 12 months
- Sean Brynjelsen - $9.91M in ETON purchases and sales in the last 12 months
- Opaleye Management Inc. - $6.89M in ETON purchases and sales in the last 12 months
- Paul V. Maier - $5.91M in ETON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Norbert G. Riedel?
Norbert G. Riedel is a corporate insider, tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Norbert G. Riedel submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Norbert G. Riedel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($656K) across all tracked filings.
